Table 1. The selected HTL epitopes for the final vaccine construction.
|
HTL epitope |
Percentile rank |
Adjusted rank |
Antigenicity |
Allergenicity |
Toxicity |
|
LLTWLGLNSRSTSLS |
2.50 |
2.50 |
1.4511(Probable ANTIGEN) |
PROBABLE NON-ALLERGEN |
Non-Toxin |
|
ILLTWLGLNSRSTSL |
3.30 |
3.30 |
1.4712 (Probable ANTIGEN) |
PROBABLE NON-ALLERGEN |
Non-Toxin |
|
LTWLGLNSRSTSLSM |
3.50 |
3.50 |
1.9214 (Probable ANTIGEN) |
PROBABLE NON-ALLERGEN |
Non-Toxin |
|
GILLTWLGLNSRSTS |
6.00 |
6.00 |
1.3691 (Probable ANTIGEN) |
PROBABLE NON-ALLERGEN |
Non-Toxin |
|
LLTWLGLNSRSTSLS |
2.50 |
2.50 |
1.4511 (Probable ANTIGEN) |
PROBABLE NON-ALLERGEN |
Non-Toxin |
|
ILLTWLGLNSRSTSL |
3.30 |
3.30 |
1.4712 (Probable ANTIGEN) |
PROBABLE NON-ALLERGEN |
Non-Toxin |
|
LTWLGLNSRSTSLSM |
3.50 |
3.50 |
1.9214 (Probable ANTIGEN) |
PROBABLE NON-ALLERGEN |
Non-Toxin |
|
GILLTWLGLNSRSTS |
6.00 |
6.00 |
1.3691 (Probable ANTIGEN) |
PROBABLE NON-ALLERGEN |
Non-Toxin |